Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-07-11

FDA Approved: AMLODIPINE BESYLATE — Original Application (POLYGEN PHARMACEUTICALS INC.)

View source ↗

Summary

FDA approved the original application for amlodipine besylate by Polygen Pharmaceuticals Inc., broadening access to a generic calcium channel blocker used to tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

ORIG AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)